Study: Women survive cancer more but face higher treatment toxicity
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 Why are men missing cancer tests despite higher positive rates?Why are men missing cancer tests despite higher positive rates?
 
A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.
 
 
 Study: Women survive cancer more but face higher treatment toxicityStudy: Women survive cancer more but face higher treatment toxicity
 
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.
 
   Tumor debulking fails to improve survival in colorectal cancerTumor debulking fails to improve survival in colorectal cancer
 
Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse effects, questioning its efficacy.
 
   Study explores if wastewater can track colorectal cancer at population levelStudy explores if wastewater can track colorectal cancer at population level
 
A proof-of-concept study shows that cancer-linked RNA can be detected in wastewater, raising the possibility of tracking colorectal cancer patterns across communities without relying on individual screening.
 
   Blood-based test helps personalize breast cancer care for older patientsBlood-based test helps personalize breast cancer care for older patients
 
For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized treatment decisions.
 
 Cancer cells rely on glutathione as fuel for growth
 
Cancer cells rely on glutathione as fuel for growthResearchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors use this nutrient.
 
 
 Aptamer Group launches targeted radiopharmaceutical program
 
Aptamer Group launches targeted radiopharmaceutical programAptamer Group plc, the developer of next‑generation synthetic binders for the life sciences industry, today announced the launch of a new targeted radiopharmaceutical program in collaboration with Radiopharmium Ltd, a UK-based specialist consultancy in radiopharmaceutical development.
 
 
 Combination therapy shows promise for leptomeningeal metastasis in breast cancer
 
Combination therapy shows promise for leptomeningeal metastasis in breast cancerPatients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.
 
 
 New tool helps identify fake medicines through pill dissolution patterns
 
New tool helps identify fake medicines through pill dissolution patternsFake news can be tricky to spot, but spotting fake drugs just got a little easier. Researchers have devised a low-cost way to help distinguish legitimate medications from counterfeit ones.
 
 
 New approach developed to visualize proteins at unprecedented scale and sensitivity
 
New approach developed to visualize proteins at unprecedented scale and sensitivityProteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest questions.
 
 
 New pathway explains poor response to bladder cancer immunotherapy
 
New pathway explains poor response to bladder cancer immunotherapyResearchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well to immunotherapy.
 
 
 Lysosomal storage of drugs may influence cancer treatment outcomes
 
Lysosomal storage of drugs may influence cancer treatment outcomesOne of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others.
 
 
 Home-based chemotherapy proves to be safe and feasible in pilot study
 
In a study published in NEJM Catalyst, Mayo Clinic researchers have demonstrated that chemotherapy can be safely delivered in patients' homes.
 
 
 Study reveals new dual role of ezrin in osteosarcoma
 
Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a well-known cancer-related protein called ezrin.
 
 
 New nanomaterial enhances bioimaging and targeted cancer drug delivery
 
The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) in Brazil has discovered a way to transform hydroxyapatite, a bioceramic material, into a nanoparticle with enhanced intrinsic luminescence.
 
 
 Protein targeted by cancer drugs may help the body fight influenza
 
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX).
 
 
 New CAR-T cell therapy shows promise for treating osteosarcoma
 
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years.
 
 
 Implantable device boosts immune cells to fight cancer effectively
 
Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026